OptimizeRx Corp Quarterly Goodwill in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
OptimizeRx Corp quarterly Goodwill history and growth rate from Q4 2018 to Q3 2024.
  • OptimizeRx Corp Goodwill for the quarter ending September 30, 2024 was $70.9M, a 213% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $70.9M +$48.2M +213% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $78.4M +$55.7M +246% Jun 30, 2024 10-Q 2024-08-15
Q1 2024 $78.4M +$55.7M +246% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $78.4M +$55.7M +246% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $22.7M $0 0% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $22.7M $0 0% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $22.7M +$7.93M +53.8% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $22.7M +$7.93M +53.8% Dec 31, 2022 10-K 2024-04-15
Q3 2022 $22.7M +$7.93M +53.8% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $22.7M +$7.93M +53.8% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $14.7M $0 0% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $14.7M $0 0% Dec 31, 2021 10-K 2024-04-15
Q3 2021 $14.7M $0 0% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $14.7M $0 0% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $14.7M $0 0% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $14.7M $0 0% Dec 31, 2020 10-K 2023-03-10
Q3 2020 $14.7M +$11.1M +301% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $14.7M +$11.1M +301% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $14.7M +$11.1M +301% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $14.7M +$11.1M +301% Dec 31, 2019 10-K 2021-03-08
Q3 2019 $3.68M Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $3.68M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $3.68M Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $3.68M Dec 31, 2018 10-K 2020-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.